Evidence map›Paper›PMID 41381594›Full record

ArticleNature communications2025

Hepatic metabolic reprogramming in male mice during short-term caloric restriction involves enhanced glucocorticoid rhythms.

Konstantinos Makris, Vlera Fonda, Fania Feby Ramadhani, Lina Fadel, Morgane Davezac, Bertrand Payet, Ioannis K Deligiannis, Liwei Zhang, Teresa Horn, Laura Heimerl and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Konstantinos Makris *Institute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany.ORCID http://orcid.org/0000-0002-9404-5706
Vlera Fonda *Institute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany.ORCID http://orcid.org/0009-0001-4121-908X
Fania Feby Ramadhani *Institute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany.ORCID http://orcid.org/0000-0003-3323-165X
Lina Fadel *Institute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany.ORCID http://orcid.org/0000-0002-4980-542X
Morgane DavezacInstitute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany.
Bertrand PayetInstitute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany.
Ioannis K DeligiannisHelmholtz Pioneer Campus (HPC), Helmholtz Munich, Neuherberg, Germany.
Liwei ZhangHelmholtz Pioneer Campus (HPC), Helmholtz Munich, Neuherberg, Germany.
Teresa HornInstitute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany.
Laura HeimerlInstitute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany.
Céline JouffeInstitute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany.ORCID http://orcid.org/0000-0002-7176-4724
Marjolein HeddesInstitute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany.ORCID http://orcid.org/0000-0002-0979-7314
Celia P Martinez-JimenezHelmholtz Pioneer Campus (HPC), Helmholtz Munich, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-9534-6201
Fabiana QuagliariniInstitute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany. fabiana.quagliarini@helmholtz-munich.de.ORCID http://orcid.org/0000-0002-1384-4857
N Henriette UhlenhautInstitute for Diabetes and Endocrinology (IDE), Helmholtz Munich and German Center for Diabetes Research (DZD), Neuherberg, Germany. henriette.uhlenhaut@helmholtz-munich.de.

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 213249687Deutsche Forschungsgemeinschaft (German Research Foundation) 314061271Deutsche Forschungsgemeinschaft (German Research Foundation) 490946138EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ERCCoG GRACE 101086997
6 · The paper itself

Abstract

Caloric restriction prolongs lifespan and preserves health across species, with feeding times synchronized to day-night cycles further maximizing benefits. However, the mechanisms linking diet, diurnal rhythms, and lifespan remain unclear. In mice, the time point most strongly tied to dietary effects on lifespan coincides with the peak of glucocorticoid secretion (ZT12, lights-off). Caloric restriction raises circulating glucocorticoid hormone levels, implicating these signals as candidate mediators for its benefits. Here we show that in the liver, the glucocorticoid receptor (GR) is required for the metabolic response to caloric restriction. Hepatocyte-specific GR mutant males fail to mount this response, indicating that increased glucocorticoid amplitude is necessary for the adaptation. Using multiomics, we find that nutrient deprivation elicits a nuclear switch from active STAT signaling to increased FOXO1 activity, enabling GR to activate diet-specific gene expression programs. Our results suggest that glucocorticoid rhythms are crucial for caloric restriction-induced metabolic reprogramming.

Indexed as

Caloric RestrictionCircadian RhythmGlucocorticoidsLiverAnimalsForkhead Box Protein O1HepatocytesMaleMetabolic ReprogrammingMiceMice, Inbred C57BLMice, KnockoutReceptors, GlucocorticoidSignal TransductionForkhead Box Protein O1Foxo1 protein, mouseGlucocorticoidsReceptors, Glucocorticoid

Identifiers

PMID41381594
PMCPMC12700935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.